Livzon Pharmaceutical Group Inc. (HKG:1513)
Hong Kong · Delayed Price · Currency is HKD 29.06
-0.24 (-0.82%)
Jan 21, 2026, 1:25 PM HKT
HKG:1513 Market Cap
HKG:1513 has a market cap or net worth of 32.43 billion as of January 20, 2026. Its market cap has increased by 1.12% in one year.
Market Cap
32.43B
Enterprise Value
26.01B
Revenue
12.95B
Ranking
n/a
PE Ratio
13.85
Stock Price
29.06
Market Cap Chart
Since July 14, 1997, HKG:1513's market cap has increased from 365.70M to 32.43B, an increase of 8,767.21%. That is a compound annual growth rate of 17.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 32.43B | 4.26% |
| Dec 31, 2025 | 31.10B | -4.81% |
| Dec 31, 2024 | 32.67B | 4.83% |
| Dec 29, 2023 | 31.17B | 0.42% |
| Dec 30, 2022 | 31.04B | -21.73% |
| Dec 31, 2021 | 39.66B | 0.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 291.88B |
| Hansoh Pharmaceutical Group Company | 260.32B |
| JD Health International | 215.66B |
| WuXi Biologics | 164.43B |
| Innovent Biologics | 155.25B |
| Sino Biopharmaceutical | 124.24B |
| CSPC Pharmaceutical Group | 112.39B |
| Akeso | 111.46B |